Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ130013010,39
KB116511660,78
PKN94,3494,351,28
Msft487,03487,550,30
Nokia5,5025,5060,51
IBM301,17302,990,17
Mercedes-Benz Group AG59,6459,66-0,32
PFE25,2625,280,32
22.12.2025 13:02:41
Indexy online
AD Index online
select
AD Index online
 

  • 11.12.2025 8:00:48
Medifast (MDFT.F, Frankfurt)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
9,66 5,78 0,54 966
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 22.12.2025
Popis společnosti

Business Summary: Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Medifast Inc revenues decreased 36% to $310.7M. Net loss totaled $553K vs. income of $1.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net loss reflects Research & Development Expense increase of 3% to $3.3M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from $0.12 to -$0.05.



  • Poslední aktualizace: 22.12.2025
Management společnosti
Data nejsou k dispozici